-
31 July 2025 23:26:33
- Source: Sharecast

31 July 2025
capAI plc
(the "Company" or "capAI")
R42 Institute Final Demo Day - In Association with capAI
capAI (LSE: CPAI) is pleased to share details of the upcoming R42 Institute Final Demo Day, where a pioneering new generation of innovators will showcase their work across AI, media and longevity.
This year's Demo Day, presented by the R42 Institute and supported by capAI through its strategic alliance with R42 Group LLC ("R42"), will feature presentations from R42 Fellows who have developed some standout projects.
Event Date: Thursday, 22 August 2025
Register now: Zoom Registration Link
All times listed below are in London time
Agenda (London Time)
16:00 - 16:15 - Opening Remarks
16:15 - 16:40 - Converting a Book to a Game
16:40 - 17:05 - Converting a Book to a Movie
17:05 - 17:30 - Building a Longevity Ecosystem
17:30 - 17:55 - Using AI to Predict the Stock Market
17:55 - 18:20 - Building a Longevity Portal for Personal Health
18:20 - 18:45 - Making AI Fine Tuning Easy Without Code
18:45 - 19:10 - Creating Author42 - A Book Writing AI Platform
(Write and edit your bestseller with Author42 and the help of AI)
19:10 - 19:25 - Closing & Networking
capAI has signed a Licence and Option Agreement in respect of Author42, an AI-powered writing platform that will be showcased at the event. The Company views this agreement as an example of the type of opportunity that may emerge under its strategic alliance with R42.
With the current exception of Author42, all projects showcased are independent of capAI, and the Company is not involved in the development or funding of any other projects featured during the Demo Day. Nonetheless, capAI believes the event offers a valuable insight into the creativity, technical innovation, and entrepreneurial energy fostered within the R42 network.
Enquiries
Company:
capAI plc hello@capaiplc.com
Broker Enquiries:
Peterhouse Capital Limited Tel: +44 (0) 207 469 0930
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.